StructuralEditorial CommentBalloon Aortic Valvuloplasty Today: Dead Man Walking, Die Hard, or Alive and Kicking?∗
Editorial Comment
Under an Elsevier user license
open archive
Corresponding Author
Key Words
aortic stenosis
balloon aortic valvuloplasty
transcatheter aortic valve implantation
Cited by (0)
Dr. Saia has received consulting fees from Edwards Lifesciences, Medtronic, Abbott Vascular, Eli Lilly, AstraZeneca, St. Jude Medical, Amgen, Bayer, and Boehringer Ingelheim; has served on advisory boards for AstraZeneca, Daiichi-Sankyo, Medtronic, Edwards Lifesciences, Abbott Vascular, Boston Scientific, Amgen, and Bayer; and has received speaker fees from Daiichi-Sankyo, Edwards Lifesciences, Medtronic, Abbott Vascular, Eli Lilly, Amgen, Bayer, AB Medica, AstraZeneca, St. Jude Medical, Terumo, Biosensors, and Boston Scientific.
- ∗
Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology.
© 2020 by the American College of Cardiology Foundation. Published by Elsevier.